The Kanazawa University Cancer Research Institute International Symposium 2016


On 15th of November 2016, “The Kanazawa University Cancer Research Institute (KU CRI) International Symposium 2016” was held at Kanazawa University Natural Science and Technology Library AV Hall.

After the opening remarks by KUCRI Director Oshima, Symposium started from the Keynote lecture by Emeritus Professor Jean Paul Thiery (CNRS lnstitut Gustave Roussy, France; National University of Singapore). A world leader in the field of epithelial-mesenchymal transition, especially in the area of EMT-driven cancer progression and chemoresistance, Dr. Thiery spoke on the topic of EMT in the progression of carcinoma: therapeutic Intervention. Dr. Thiery’s Keynote address was followed by two sessions of scientific presentations.

In the first Session, A/Prof. Hiromichi Ebi from the CRI & lnFiniti of Kanazawa University spoke on EMT and feedback activation of RTK signaling induced by MEK inhibition in KRAS mutant lung cancer. And he was followed by A/Prof Wai Leong Tam of the Genome Institute of Singapore and Cancer Science Institute of Singapore) who further expounded on the topic of Therapeutic vulnerabilities in cancer stem cells.

In Session 2, Prof Takeshi Suzuki (CRI & lnFiniti, Kanazawa University) and Prof Brendon Jenkins (Hudson Institute of Medical Research & Monash University, Australia) presented their latest work. Dr. Suzuki lectured on how he utilized Retroviral insertional mutagenesis to identify histone methyl-modifying enzymes involved in malignant progression of cancer, while Dr. Jenkins presented his work on the role of pattern recognition receptors and inflammasomes in gastric cancer.

At the completion of the scientific presentations, the symposium coordinator A/Prof Dominic Voon, (CRI & lnFiniti, Kanazawa University) in his closing remarks.

Participation in this Symposium awards medical students in Doctoral Course credits to contribute to the development of young researcher. This time approximately 110 students participated as part of the 180 total attendances for this successful symposium.

This symposium saw strong participation from the attendance as reflected in the studious note taking by students and researchers alike; as well as vigorous discussion in question times. These were followed by active engagement in discussion during the break time, giving our researchers a valuable opportunity interact with renown international researchers and discuss the latest trends in cancer research.